EXPERIENCE WITH IBRUTINIB IN PATIENTS WITH REFRACTORY AND RECURRENT B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Purpose of the study. To obtain experience with ibrutinib in patients with chronic lymphocytic leukemia (CLL) in everyday clinical practice.Material and methods. 20 patients with refractory or relapsed CLL were included in the study during the period from October 2015 to January 2016. Immunophenotyp...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
Remedium Group LLC
2017-06-01
|
| Col·lecció: | Медицинский совет |
| Matèries: | |
| Accés en línia: | https://www.med-sovet.pro/jour/article/view/1898 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|